Equities
IndustrialsElectronic and Electrical Equipment
  • Price (USD)338.45
  • Today's Change5.08 / 1.52%
  • Shares traded283.01k
  • 1 Year change+22.94%
  • Beta0.9585
Data delayed at least 15 minutes, as of Sep 19 2024 21:10 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Waters Corporation offers analytical instruments and software across chromatography, mass spectrometry, and thermal analysis innovations serving the life, materials, food, and environmental sciences. The Company primarily designs, manufactures, sells and services high-performance liquid chromatography (HPLC), ultra-performance liquid chromatography and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and comprehensive post-warranty service plans. Its segments include Waters and TA. The Waters segment is primarily in the business of designing, manufacturing, selling and servicing liquid chromatography (LC) and MS instrument systems, columns and other precision chemistry consumables that can be integrated and used along with other analytical instruments. The TA segment is primarily in the business of designing, manufacturing, selling and servicing thermal analysis, rheometry and calorimetry instruments.

  • Revenue in USD (TTM)2.88bn
  • Net income in USD595.69m
  • Incorporated1991
  • Employees7.90k
  • Location
    Waters Corp34 MAPLE STMILFORD 01757-3604United StatesUSA
  • Phone+1 (508) 478-2000
  • Fax+1 (508) 872-1990
  • Websitehttps://www.waters.com
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Teleflex Inc3.01bn264.76m11.38bn14.50k43.172.5021.853.785.595.5763.5496.760.41962.096.85207,437.103.695.864.006.4255.8654.438.8014.621.447.140.273715.846.573.97-1.4712.732.510.00
Revvity Inc2.71bn197.34m15.37bn11.50k78.011.9524.535.671.601.3721.9063.800.19592.894.42235,499.601.434.761.595.3955.2657.197.2915.341.986.890.32996.52-16.95-0.1982-64.99-5.28-2.690.00
Insulet Corp1.87bn395.30m16.55bn3.00k43.6216.5835.168.845.415.4124.5314.240.7111.386.25624,233.3015.012.7118.153.1469.0065.8121.114.282.7187.970.58330.0030.0224.664,384.78128.77-7.63--
Avantor Inc6.83bn360.20m18.40bn14.50k51.103.3824.172.700.52950.529510.038.000.5305.375.82470,731.002.802.973.173.3533.7133.445.285.061.053.070.48480.00-7.263.51-51.52--31.17--
Align Technology, Inc.3.94bn447.03m18.90bn21.61k42.915.0332.204.795.905.9052.0350.310.6414.164.09182,455.407.2716.3410.9624.1469.8271.7211.3423.161.06--0.000.003.4214.4523.092.15-4.46--
Hologic Inc3.99bn701.50m18.98bn6.99k27.893.8318.774.762.932.9316.5921.330.43752.646.06570,472.107.7011.408.6413.3855.4160.2917.5920.953.32709.770.34080.00-17.124.61-64.98--7.30--
Waters Corp2.88bn595.69m19.79bn7.90k33.2114.0125.136.8810.0410.0448.4623.790.63942.194.41364,118.2013.2419.7716.0425.2959.6858.4520.7123.381.428.740.58690.00-0.52294.09-9.261.534.72--
Baxter International Inc15.00bn-157.00m20.09bn60.00k--2.6318.101.34-0.30664.8729.4814.980.55343.245.73249,950.00-0.54620.1942-0.70190.233336.4838.20-0.98690.36740.91474.250.6261,398.942.125.9497.15--0.9829.71
Illumina Inc4.43bn-3.04bn20.86bn10.59k--14.50--4.71-19.18-19.1827.949.030.49612.866.26418,224.80-34.09-6.20-45.61-7.2862.0066.39-68.71-15.480.859614.070.6087---1.756.2173.64---7.91--
Zimmer Biomet Holdings Inc7.52bn997.10m21.64bn18.00k22.151.7111.032.884.804.8036.2262.180.35150.91415.40418,050.004.662.215.402.5271.7871.2513.277.280.6297.510.31438.906.55-1.40252.86--9.440.00
Cooper Companies Inc3.80bn359.30m22.01bn15.00k61.552.7829.905.791.801.8019.0239.800.31961.705.56253,606.703.0210.063.2911.3466.3665.549.4529.001.185.460.24930.34698.617.24-23.74-3.6615.1831.95
West Pharmaceutical Services Inc.2.88bn524.90m22.43bn10.60k43.938.7134.237.807.047.0438.6235.490.80374.265.68271,405.7014.2215.6116.9318.6535.6938.0617.7018.471.68--0.075110.692.1811.432.2823.7628.166.20
Steris PLC5.13bn567.70m23.51bn18.18k41.663.7121.194.585.724.0351.7364.320.49143.985.77282,395.105.455.195.955.6843.1943.6411.0910.971.497.030.266636.5613.2813.06-1.0712.6713.698.83
DexCom Inc3.93bn666.90m27.83bn9.60k43.6111.4331.917.071.591.599.386.080.57782.924.64409,875.009.798.3013.5710.5063.1665.9016.9514.142.48--0.50630.0024.4928.5658.70--28.66--
Data as of Sep 19 2024. Currency figures normalised to Waters Corp's reporting currency: US Dollar USD

Institutional shareholders

48.21%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 30 Jun 20246.76m11.39%
Fundsmith LLPas of 30 Jun 20244.88m8.22%
BlackRock Fund Advisorsas of 30 Jun 20243.86m6.50%
SSgA Funds Management, Inc.as of 30 Jun 20242.53m4.26%
Massachusetts Financial Services Co.as of 30 Jun 20242.42m4.07%
AllianceBernstein LPas of 30 Jun 20242.36m3.97%
Generation Investment Management LLPas of 30 Jun 20241.81m3.05%
Walter Scott & Partners Ltd.as of 30 Jun 20241.62m2.73%
Geode Capital Management LLCas of 30 Jun 20241.40m2.36%
GuardCap Asset Management Ltd.as of 30 Jun 2024983.58k1.66%
More ▼
Data from 30 Jun 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.